chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flared up Multiple sclerosis; flared up optic Neuritis; numbness; pressure at the base of her neck; head pressure; headache; muscle problems in mouth; problems in mouth with speech; problems in mouth with speech and swallowing; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation; hydrocortisone, neomycin sulfate, polymyxin b sulfate (CORTISPORIN), via an unspecified route of administration from an unspecified date at an unknown dose and frequency for an unspecified indictaion. The patient's medical history and concomitant medications were not reported. It was reported that the patient got the vaccine and when the shot was given had a wave of numbness and pressure at the base of her neck and intense head pressure that flared up optic neuritis. Extreme headache and still has it since getting the vaccine on Friday. It caused muscle problems in mouth with speech and swallowing, flared up multiple sclerosis. The outcome of the events was unknown.   Information on the lot/ batch number has been requested.
Sore shoulder; Faint redness on arm; Weakness; Soreness of the stomach; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore shoulder), ERYTHEMA (Faint redness on arm), ASTHENIA (Weakness) and ABDOMINAL PAIN UPPER (Soreness of the stomach) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced ARTHRALGIA (Sore shoulder), ERYTHEMA (Faint redness on arm), ASTHENIA (Weakness) and ABDOMINAL PAIN UPPER (Soreness of the stomach). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, ARTHRALGIA (Sore shoulder), ERYTHEMA (Faint redness on arm) and ASTHENIA (Weakness) outcome was unknown and ABDOMINAL PAIN UPPER (Soreness of the stomach) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported.
A report has been received from a Health Professional concerning a patient, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST (intranasal) started on an unknown date. The patient experienced inadvertent administration to a 70 year old. The outcome of the event of inadvertent administration to a 70 year old is unknown. The report was considered to be non-serious.
give expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB08AZ, expiry date 31st March 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 14th April 2022, the patient received Bexsero and Bexsero Pre-Filled Syringe Device. On 14th April 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 14th Apr 2022 Reporter's Comments:  The health care professional reported that one of her colleagues give by error a Bexsero expired dose to a patient. The reporter consented to follow up by email. Additional Supportive Information: The patient received a dose of Bexsero which was already expired which led to expired vaccine used.
Given the 4 vaccines and as walking out of room patient had witnessed tonic-clonic seizure in father's arms. Body stiffened/jerking, eyes rolled back/staring, vomited. Lasted 2-3 min. EMS called and took patient to hospital.
Constant headache, had moments where it felt like a jolt of pain shot from my scalp all the way through my brain, extreme exhaustion, skin felt like nerve endings were hypersensitive, injection arm hurt, couldn't lift it without pain,
CHILLS; PAIN IN HANDS; HEADACHE; VERY TIRED; MUSCLE ACHES; PAIN IN ELBOW; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient did not have known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029,  expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced chills. On 13-MAR-2021, the subject experienced pain in hands. On 13-MAR-2021, the subject experienced headache. On 13-MAR-2021, the subject experienced very tired. On 13-MAR-2021, the subject experienced muscle aches. On 13-MAR-2021, the subject experienced pain in elbow. Treatment medications included: diphenhydramine hydrochloride, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 14-MAR-2021, was recovering from pain in hands, and pain in elbow, and had not recovered from very tired, muscle aches, and chills. This report was non-serious.
terribly sick for nearly a month right after; Initial information received on 07-Feb-2022 regarding an unsolicited valid Social Media non-serious case received from patient.  This case involves 3 adult patients of unknown demographics who experienced terribly sick for nearly a month right after while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, patients have started taking suspect INFLUENZA VACCINE (dose, route, strength, frequency, lot details are unknown) in an unknown administration site for immunization. Information on batch number has been requested.  On an unknown date the patients have developed a non-serious event of terribly sick for nearly a month right after (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported, posted a comment on Flu Shot Social Medical page where Three friends in this town all got the flu shot the same week. All three were terribly sick for nearly a month right after. So much for safety and effectiveness.  Action taken was unknown.  It was not reported if the patients have received a corrective treatment for the event (terribly sick for nearly a month right after).  At time of reporting, the outcome was Unknown for the event terribly sick for nearly a month right after.
large 6 x 7 cm erythema and mild induration, warm on left lateral and anterior thigh, itchy
Moderna COVID-19 Vaccine EUA Left arm got very sore overnight, could hardly move left arm in the am due to pain at injection site, felt like I was sick with covid again,  headache, chills, tired, no appetite, muscle and joint pain all over. Had to stay home from work because I could not lift my arm above my head.
Positive COVID test 07/26/2021, mild to moderate respiratory symptoms, not hospitalized as of this date
Immediately following vaccine:  itching and headache, then extreme fatigue and stabbing abdominal pain, followed by diarrhea.   The next morning, I felt fine and went to work,  but by 2pm, I felt like I had been hit by a truck - headache, aches, chills, felt feverish (but no fever), diarrhea.  On 3/13, felt a bit better, but still fatigued and had diarrhea.  Had chills off and on throughout the day.  3/14 felt a bit better, but had fatigue and body aches plus diarrhea.  3/15, severe body aches, chills, headache, diarrhea.  3/16 severe body aches and pains, chills, severe headache, feel feverish (but no fever).
heart arrhythmia, two separate episodes of syncope, lasted hours, tachycardia low blood pressure dizziness, disorientation, weakness, blurry vision, clammy, overheating
severe muscles aches which lasted 3 weeks; This case was reported by a pharmacist and described the occurrence of myalgia in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number KY5T4, expiry date unknown) for prophylaxis.   On 22nd October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 22nd October 2020, less than a day after receiving Shingrix, the patient experienced myalgia. On an unknown date, the outcome of the myalgia was recovered/resolved.   It was unknown if the reporter considered the myalgia to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient had severe muscle aches. The reporter did not consent to follow up.
Swelling and redness for several days in the vaccine area causing severe pain in the area. Itchy rash in several areas of the body.
Allergic reaction to flu vac. Seen at walk in clinic. 3-4 inch diameter.
large red, hard, and swollen area- encompassing almost the entire upper arm. bruising also present. very painful and hot to the touch. borders were marked and area continued to grow in size over the next two days. benadryl, tylenol, and motrin given continuously over 3 days for pain & swelling. ice also applied for the last 3 days called the doctor's office and told to continue doing meds as we have been doing. UNSURE OF BRAND OR LOT # OF FLU VACCINE
Suspect myocarditis/myocardial injury: Palpitations, headaches, fatigue within 24 hours of injection. Patient went to ER 11/5/22. I saw her 11/18/22 for follow up in family practice clinic.
Patient started with fevers, respiratory issues, red eyes on 3/1/19. Rash started on 3/3/19.
Swelling and sunburn feeling in right eyebrow, right eyelid, right inner ocular area. Itching and sensitivity in left outer earlobe.
Extended time since first dose; shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) and WRONG SCHEDULE (Extended time since first dose) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    In March 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced HERPES ZOSTER (shingles). On an unknown date, the patient experienced WRONG SCHEDULE (Extended time since first dose). At the time of the report, HERPES ZOSTER (shingles) and WRONG SCHEDULE (Extended time since first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported being treated with antivirals for 10 days. Patient took vitamins daily.It was unknown if patient received second dose.
Headache, Myalgia, Hip/joint pain, ear ache fatigue Narrative:
Stroke 6 days after receiving the second dose of the vaccine; Paralysed left side; Fell on the floor unresponsive; Fell on the floor Unresponsive; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CEREBROVASCULAR ACCIDENT (Stroke 6 days after receiving the second dose of the vaccine), PARALYSIS (Paralysed left side) and UNRESPONSIVE TO STIMULI (Fell on the floor unresponsive) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was reported). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Stroke 6 days after receiving the second dose of the vaccine) (seriousness criteria hospitalization and medically significant), PARALYSIS (Paralysed left side) (seriousness criteria hospitalization and disability), UNRESPONSIVE TO STIMULI (Fell on the floor unresponsive) (seriousness criteria hospitalization and medically significant) and FALL (Fell on the floor Unresponsive). The patient was hospitalized on 10-Mar-2021 due to CEREBROVASCULAR ACCIDENT, PARALYSIS and UNRESPONSIVE TO STIMULI. The patient was treated with Surgery for Cerebrovascular accident and Surgery for Paralysis. At the time of the report, CEREBROVASCULAR ACCIDENT (Stroke 6 days after receiving the second dose of the vaccine), PARALYSIS (Paralysed left side), UNRESPONSIVE TO STIMULI (Fell on the floor unresponsive) and FALL (Fell on the floor Unresponsive) outcome was unknown. Not Provided          Medical history was not reported. The patient was taking unspecified Antihypertensive medication. The patient was placed on a feeding tube and was transferred to a Nursing home and would require medical service for the rest of her life.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
dose was the 6th of the series; an 11-year-old patient received a dose of Infanrix; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 11-year-old female patient who received DTPa (Infanrix) (batch number 7C9NJ, expiry date 02-NOV-2024) for prophylaxis.   On 16-MAY-2023, the patient received Infanrix. On 16-MAY-2023, an unknown time after receiving Infanrix, the patient experienced extra dose administered (Verbatim: dose was the 6th of the series) and inappropriate age at vaccine administration (Verbatim: an 11-year-old patient received a dose of Infanrix).  The outcome of the extra dose administered and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 22-Aug-2023 The pharmacist called to inform that an 11-year-old patient received a dose of Infanrix on, which led to inappropriate age at vaccine administration.  According to the reporter the dose was the 6th of the series, which led to extra dose administration. The reporter consented to follow up.
Slight Dizziness, BP 134/92, Pulse 90%, o2 98%. Patient transferred to , advised to drink some water, vitals checked, patient stayed 30 min in observation vitals 124/68, pulse 84. Patient feels better, advised to consult with PCP if she feels symptoms [other than expected] again. Educate Regarding after vaccination care instructions
The patient complained of feeling nausea, tingling of hands and feeling of passing out after 5 minutes after injection. Patient layed on the floor with a bag of ice on her head. I stayed with patient and asked how she was feel any shortness of breath/difficulty breathing and she expressed feeling of nausea and no feeling in hands and feet. Patient was monitored and had an increase of symptoms. Patient did not show signs of anaphylaxis but complaints remained the same therefore I informed patients of injection Benadryl 50mg/ml IM shot would be given. 911 was called and arrived approximately 10 minutes. Patient felt better atfer 5-10 minutes from receiving Benadryl and was able to get of the floor on her own. EMS check vitals Blood pressure of 106. Was told she had an reation by EMS and to follow up with a visit to the ER.
After Patient received second dose of Pfizer vaccine they disclosed to RN that they received Janssen Vaccine on 5/29/21. Patient recieved first dose of pfizer on 8/6/21 from a clinic. Only the Pfizer dose was present in patients vaccination record.Patient has received two complete series of CV19 vaccinations. Pfizer and Janssen
she ended up on the floor at the store; Whole left side; radial pulse and everything was gone; Whole left side; radial pulse and everything was gone; Freezing, could not get warm; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 05Feb2021 12:30 (Lot Number: EL9269) 1ST DOSE, single for COVID-19 immunization. Medical history included ongoing chronic obstructive pulmonary disease (COPD) and asthma. There were no concomitant medications. The patient not received prior vaccinations (within 4 weeks). No additional vaccines administered on same date of the Pfizer suspect. The patient reported that she received her first vaccine dose on 05Feb2021 and initially was instructed to get the second dose 2 weeks later. 30 minutes after getting the first dose she experienced a reaction, she thought she was having a stroke and she was transported to the ER for evaluation and found out it wasn't a stroke. Reports that because of her reaction, her ER doctor advised her not to get the second dose. But her primary doctor advised her to get the second dose at 3 weeks instead of 2 weeks after the first. She was planning to get her second dose 3 weeks after the first dose but her son died and she missed her appointment. Since then she has relocated to other state. It was further reported as follows: she waited 15 minutes after the vaccine and felt fine. She then went to the store and ended up on the floor at the store and had to be taken out of the store by ambulance. Her whole left side; her radial pulse per the Emergency Medical Technicians, was gone. She thought she was having a stroke but all of her tests at the hospital were negative. She was freezing and could not get warm. They put warming blankets on her. They did an MRI and a CT Scan and everything was fine. Symptoms lasted a couple of hours, then were gone. Emergency Room Nurses and Paramedics said she should get the second dose of the vaccine. The patient wants to be fully vaccinated. From the time she got her vaccine to the time they had to call the ambulance, it was about an hour. The patient missed her appointment for her second dose of the vaccine and still has not gotten it. Outcome of events recovered on 05Feb2021.
pt recvd vax & exp severe pain @ the inject site & the entire arm, CNS involvement consisting of tingling, numbness & heaviness in the injected arm, lightheadedness, & dizziness; No further details were provided;
This spontaneous report was received from a 66 year old female patient, referring on herself. The patient's concurrent conditions included hypersensitivity (reported as allergy to CIPRO), gastrooesophageal reflux disease (reported as acid reflux) and asthma. On 08-DEC-2015 the patient was vaccinated with a single dose of ZOSTAVAX, subcutaneous route, 1 shot, (dose, lot number, expiry date and administration site were unknown) (reported as "for shingles"). Concomitant therapies included NEXIUM. In December 2015, a few days after the vaccination with ZOSTAVAX, the patient experienced pruritus generalized (itchiness on the scalp ...spread to all over her body), rash (rash on her neck) and formication (similarly to the experience of skin crawling). The patient sought medical attention for the reported events and was prescribed with Prednisone as treatment (manufacturer unknown), but she was not satisfied with the results. At the time of this report, the outcome of pruritus, rash and formication was not recovered. The reporter did not provided a causality among the reported events and the ZOSTAVAX vaccination. Additional information has been requested.
Shortly after adminstering vaccinations patient felt dizzy. She had a seat on the bench by pharamcy for 15 minutes. After 15 minutes she felt fine and left the store with her parents.
During pt observation after receiving COVID-19 vaccine, pt complained of feeling as if her chest was feeling tight. RN requested on site MD to come over and evaluate. After several minutes of MD speaking with pt, pt stated she felt as if her chest tightening was getting worse and it was painful and that her throat was "feeling weird". MD stated to alert on site Medics and have them complete further evaluation. Medics completed their eval and had on site first responder request an ambulance to further evaluate pt. EMS arrived at 1028 and after completing their evaluation of pt, it was determined to take pt to the hospital for further evaluation. Pt significant other drove their personal vehicle home. Pt was transported via  ambulance at 1045 in stable condition to the hospital.
On 09/15/2021 -shortness of breath, like when I would walk to my car. It would usually happen when I would sit down. I would  realize I was not breathing for like 5-10 seconds. I basically had to gasp for air.  10/08/2021- I went to see Dr. for a physical. I told him about my shortness of breath and he order a chest x-ray.  10/11/2021- chest x-ray- the results were inconclusive. Basically negative.  It is unknown if I have recovered from my shortness of breath. It does not happen as frequently.
Redness, swelling, hot to touch. Pain at injection site. This is my second vaccine for this in 1.5 years. I got both during pregnancies . My first baby was born and weighed 8lbs 1oz. My second baby is due February 12, 2021
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown ages and genders. There was no information about the patients' pertinent medical history, concomitant medications, drug reactions or allergies provided. On unspecified dates, the patients were vaccinated with improperly stored GARDASIL 9 (lot # M042853 with the expiration date of 17-JUL-2019; dose number, exact dose and route of administration were not reported), for prophylaxis. No adverse effects were reported. The administered doses of vaccine experienced a temperature excursion of 51 Fahrenheit degrees for 15 minutes. Digital data logger was used to capture the temperature excursion. There were no previous temperature excursions reported. This was one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1708USA005640: US-009507513-1708USA005641:
pt recv vax & MD prescribed unspecified pills to treat a poss urinary tract infect; 2 days later felt a rush of fluid up neck & vomited;pt reported this to MD who told her to stop the pills;
This case was reported by a consumer and described the occurrence of watery eyes in a 58-year-old male subject who was vaccinated with (FLULAVAL, GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject has had flu vaccinations in the past, but is unsure which vaccines they were. The subject did not experience any reactions with previous flu shots. The subject had no adverse events following previous vaccinations. On 14 October 2008 the subject received unspecified dose of FLULAVAL (.5 ml, unknown, left arm). On 16 October 2008, 2 days after vaccination with FLULAVAL, the subject experienced watery eyes. According to the reporter, all diagnostic tests so far have been negative; no glaucoma and no blocked tear ducts. At the time of reporting the event was unresolved.